Trinity Biotech | TRIB - Pre Tax Profit


Trinity Biotech reported $-5.06M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Bayer EUR 321M 2.67B Jun/2026
Bio-Rad Laboratories USD 542.1M 1.23B Jun/2026
EDAP TMS EUR -8.94M 4.03M Mar/2026
J&J USD 8.66B 839M Jun/2026
Mesa Laboratories USD -2.22M 6.03M Dec/2024
OraSure Technologies USD -18.43M 5.14M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Roche Holding CHF 11.17B 6.38B Jun/2026
Siemens EUR 2.86B 89M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Tosoh JPY 33.18B 3.4B Jun/2026
Trinity Biotech USD -5.06M 10.74M Sep/2025
Veracyte USD 26.52M 3.45M Jun/2026